Navigation Links
Health Experts Call for New Strategies to Combat Alarming Rise in Diabetes

PARIS, September 25 /PRNewswire/ --

- Johnson & Johnson Diabetes Institute Launched as New Research Suggests Improved Patient Education May Play Key Role in Halting Escalating Disease in the EMEA Region

Experts have predicted that by 2025, the number of people with diabetes will have increased by 20 per cent within Europe, 80 percent within Eastern Mediterranean and Middle Eastern populations and 80 percent within the African patient population(1). Diabetes specialists and patients agree that improved education for healthcare professionals and patients could, however, reduce both the financial and personal impact of diabetes on our society.

New research unveiled today at the opening of the Johnson & Johnson Diabetes Institute in Paris, a new state-of-the art diabetes training facility for healthcare professionals involved in diabetes care across Europe, the Middle East and Africa (EMEA), reinforced this belief and showed overwhelming support for improved education measures as a key enabler for patients to better manage the condition.

"With global health expenditure for diabetes and its complications set to exceed US$302.5 billion by 2025, a 30 per cent increase, and some of the largest segments of that expected in Europe, the Middle East and Africa, we interviewed patients and healthcare professionals in six countries representative of this vast region, to see what practical solutions were needed", said former Acting U.S. Surgeon General, Kenneth Moritsugu M.D., M.P.H., FACPM, who serves as the Global Johnson & Johnson Diabetes Institutes' Chairman.

"92% of healthcare professionals surveyed believe patient education can help reduce the burden of diabetes on society, yet despite this, 58% of those patients surveyed want more information and advice from their healthcare professional on how to better manage the disease. This discrepancy can be explained by the fact that healthcare professionals themselves are seeking new and improved training and tools to help in engaging and empowering patients to master their diabetes."

For these reasons, a key aim of the newly opened Johnson & Johnson Diabetes Institute will be to raise the level of care for people with diabetes in the EMEA, through improved education for healthcare professionals, achieved in partnership and collaboration with leading professional societies and experts in the field.

The Johnson & Johnson Diabetes Institute's commitment to improved education as a priority within the EMEA was validated by findings from a research report developed by the Johnson and Johnson Diabetes Institute EMEA and the London School of Economics. The report, Diabetes: Tipping Point or Turning Point?, includes results from detailed interviews with healthcare professionals and patients across the region and extensive analysis of current research, representing a unique attempt to highlight the known escalation of the burden of diabetes across the EMEA and the unmet need for improved educational opportunities for physicians and patients.

"Research shows that in developed nations, health expenditure for diabetes care is higher than it need be because not enough is being spent aiming at the prevention of major diabetes-related complications such as heart disease, stroke, kidney disease and amputations," said Dr. Maria Raikou, a health economist at The London School of Economics and report co-author.

Other highlights from the report include:

- 92 percent of physicians surveyed believe patient education

can help reduce the burden of disease on society(2).

- 73 percent of healthcare professionals surveyed would like

an increase in the number and quality of tools available to educate


- 82 percent of healthcare professionals surveyed believe

education is central to the successful management of diabetes(4).

- As many as 60 percent of patients surveyed in the European

Union (EU) and 87 percent in non-EU countries have not been given an

opportunity to participate in educational initiatives about their


The report findings also highlight a perceived failure of policymakers within the EMEA to provide adequate funding for educational measures. Most healthcare professionals surveyed felt that current healthcare policies being implemented for diabetes by national governments are not placing sufficient emphasis on patient education (64 percent)(6).

"The Institute will be more than just a space for healthcare professional training", said Kenneth Moritsugu, M.D. "It is the starting point of a lasting relationship with the diabetes community, a focal point for collaboration amongst healthcare professionals, policymakers, patients and their families. We hope to help improve the understanding of diabetes and subsequently, to improve patient outcomes for one of the biggest public health threats of this century."

For more information, please visit

Notes to editors

About the Diabetes: Tipping Point or Turning Point? report The Diabetes: Tipping Point or Turning Point? report was sponsored by the Johnson & Johnson Diabetes Institute and authored by a multi-disciplinary team comprised of Maria Raikou, health economist from the London School of Economics, Professor Anthony Barnett from the University of Birmingham, United Kingdom, and global market research company, TNS Healthcare.

About the Johnson & Johnson Diabetes Institute

Globally, the Johnson & Johnson Diabetes Institute provides healthcare professionals with education, training and a space for collaboration, with the aim of enhancing the understanding of diabetes and helping to improve patient outcomes.

Each Johnson & Johnson Diabetes Institute aims to ensure that diabetes specialists are able to receive skills training and education customised to reflect the needs of patients and providers in their region, as well as supporting proven guideline implementation and an efficient use of resources within diabetes care.

There are currently four instructional Johnson & Johnson Diabetes Institutes in operation worldwide (United States, Japan, China, France), with plans for further Institutes to be opened.


(1) International Diabetes Foundation (2006) Diabetes Atlas, Third


(2) `Healthcare Professional and Patient Perspectives on Diabetes

Education', Diabetes: Tipping Point or Turning Point? pg 46

(3) Ibid. pg 47

(4) Ibid. pg 46

(5) Ibid. pg 52

(6) Ibid. pg 58

SOURCE Johnson & Johnson Diabetes Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
2. Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canadas Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada
3. Fujitsu PalmSecure and HT Systems PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft
4. Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Childrens Health Care
5. Global Psychiatrists Unite to Improve Services in Mental Health
6. Cardinal Health Invites Health Care Providers to Apply for $1 Million in Grants to Fund Patient Safety Initiatives
7. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
8. Hoana Medical and Hawaii Union Health and Welfare Trust Funds Partner to Fix Healthcare
9. A Better Tomorrow Treatment Center Inc., Forterus Inc.s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
10. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
11. Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced ... 29, 2015 at 11:00 a.m. Israel time, at ... 98 Yigal Allon Street, 36 th Floor, Tel Aviv, ... Eric Paneth and Izhak Tamir to the Board of ... as external directors; , approval of an amendment to certain terms ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Inc., on being named to Deloitte's 2015 Technology Fast 500 list of the ... manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up orthodontic tooth ...
(Date:11/24/2015)... MUNICH and NEW YORK , ... irst investment by Bristol-Myers Squibb in a ... Bristol-Myers Squibb Company in which the companies ... products in immuno-oncology and other areas of unmet medical need. ... Squibb in LSP 5, the latest LSP fund. This is ...
(Date:11/23/2015)... KONG, Nov. 23, 2015 China Cord Blood ... China,s leading provider of cord blood collection, laboratory testing, ... today announced its preliminary unaudited financial results for the ... ended September 30, 2015. --> ... , Revenues for the second quarter of fiscal ...
Breaking Biology Technology:
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/27/2015)... Oct. 27, 2015 In the present market ... concern for various industry verticals such as banking, healthcare, ... the growing demand for secure & simplified access control ... such as hacking of bank accounts, misuse of users, ... such as PC,s, laptops, and smartphones are expected to ...
(Date:10/26/2015)... PALO ALTO, Calif. and LAS ... – Nok Nok Labs , an innovator in ... FIDO Alliance , today announced the launch of its ... the first unified platform enabling organizations to use standards-based ... authentication. The Nok Nok S3 Authentication Suite is ideal ...
Breaking Biology News(10 mins):